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Abstract
Background: Although it is well known in the literature that high triglyceride serum (TG) levels can jeopardize the
metabolic control, little is known about the influence of low TG on type 1 diabetes patients (T1D). The aim of this
study is to investigate the distribution of TG serum levels in individuals with T1D and its relationship with
metabolic control.
Findings: We reviewed the medical charts of 180 patients with T1D, who were classified in groups according to
TG levels: 1) low (below 50 mg/dL); 2) normal (50-150 mg/dL); 3) high (above 150 mg/dL). TG were low in 21.1%
(n = 38; group 1), normal in 68.6% (n = 123; group 2) and high in 10.6% (n = 19; group 3). High TG was associated
with a poor metabolic control (p < 0.001). Patients with TG lower than 50 mg/dL had a lower HbA1c than those
with TG between 50 and 150 mg/dL (7.41+/-1.50% vs 8.56%+/-1.94%; p = 0.002).
Conclusion: TG lower than 50 mg/dL was common and might be associated with a better metabolic control in
patients with T1D, although it is not clear whether the former is the cause or consequence for the latter.
Introduction
Type 1 diabetes (T1D) is a chronic autoimmune disease
characterized by insulin deficiency (1). Although it is
not usually associated with obesity, insulin resistance
and hypertriglyceridemia, it is known that the increase
in the worldwide prevalence of obesity and dyslipidemia
is also affecting individuals with T1D (2). The relation-
ship between cardiovascular disease and hypertriglyceri-
demia (3) has been well established, both in type 1
diabetes (4) and type 2 diabetes (5). Insulin influences
the activity of lipase lipoprotein and therefore insulin
deficiency and poor metabolic control are associated
with hypertriglyceridemia (6). Although much is said
about hypertriglyceridemia and its importance, little is
known about the relevance of low triglyceride levels in
the general population or in those with T1D. However,
hypotriglyceridemia has been linked to autoimmune dis-
eases (7) and may be implicated in the development of
T1D in individuals at risk for the disease (8). The aim of
this study was to investigate the distribution of triglycer-
ide (TG) serum levels in individuals with T1D and its
possible clinical implications.
Research design and methods
We performed a retrospective analysis of the medical
charts of patients with T1D at the Hospital Universitario
Clementino Fraga Filho, in Rio de Janeiro. All patients
signed an informed consent and the protocol was
approved by the Institutional Review Board. Clinical
data, cholesterol, triglycerides, serum glucose and gly-
cated hemoglobin (HbA1c) were retrieved. Patients were
classified in three groups according to their TG levels:
1) low (< 50 mg/dL); 2) normal (50 to 150 mg/dL) and
3) high TG (more than 150 mg/dL). None of patients
included were engaged in intense physical activity. Chi
Square test, Mann Whitney and ANOVA Kruskall
Wallis were used to compare groups and Spearman
coefficient was used for correlation tests. An alpha <
0.05 was employed and all tests were two-tailed. SPSS
13.0 for Windows was used for statistical analysis.
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The population comprised 180 individuals (100 women,
80 men). Their mean age, disease duration and age at
onset were 25.2 ± 8.4, 12.6 ± 7.3 and 12.7 ± 8.3 years.
Their mean insulin dose/kg of body weight ratio was
0.95 ± 0.42 U/kg and their mean body mass index
(BMI) was 23.9 ± 3.2 kg/m
2. Retinopathy was found in
15.6% and nephropathy in 17.8% (mild in all cases). 34%
were overweight and 6.4% were obese. Their mean fast-
ing glucose and HbA1c were 173.8 ± 102.9 mg/dL and
8.6 ± 2.2%. The mean serum cholesterol, HDL, LDL and
TG were 166.6 ± 39.8 mg/dL, 51.6 ± 15.6 mg/dL, 92.2 ±
29.3 mg/dL and 95.7 ± 76.8 mg/dL. High LDL levels
was seen in 35.2% (100-130 mg/dL in 78.7%, > 160 mg/
dL in 9.8% of these); 20% used statins (58.3% of these
had LDL ≥ 1 0 0m g / d L ;>1 3 0m g / d Li no n l y6c a s e s ) .
TSH was normal in 95% and 5% had subclinical
hypothyroidism. Liver diseases were not observed.
TG levels were low in 21.1% (n = 38; group 1), normal
in 68.3% (n = 123; group 2) and high in 10.6% (n = 19;
group 3). Clinical parameters according to the TG levels
are described in the table 1. HbA1c differed between
groups (p = 0.039). The difference was seen not only
between groups 3 and others (10.88 ± 3.1% vs 8.3 ±
1.9%; p < 0.001) but also between groups 1 and 2 (7.41
± 1.50% vs 8.56% ± 1.94%; p = 0.002), as shown in Fig-
ure 1. There was a direct correlation between TG and
HbA1c in the whole sample (R = 0,34; p < 0.001) and
also in those with TG < 150 mg/dL (R = 0.25; p =
0.002). The frequency of individuals with HbA1c < 7%
differed between groups 1 and 2 (34.21% vs 17.88%; p =
0.025). A trend towards a lower insulin dose/kg was also
seen in group 1 when compared to group 2 (0.84 ± 0.30
U/kg vs 1.00 ± 0.46 U/kg; p = 0.052), but not between
those and group 3 (0.84 ± 0.31 U/kg; p = 0.31).
There was a significant difference in BMI between
groups (22.5 ± 2.5 kg/m
2 24.3 ± 3.3 kg/m
2 and 24.3 ±
3.6 kg/m
2 in groups 1, 2 and 3; p = 0.018). This differ-
ence was seen only between groups 1 and 2 (p = 0.002),
and not between those and group 3 (p = 0.986). There
was no correlation between BMI and HbA1c (R = 0.038;
p = 0.64). A significant difference in LDL levels was
seen between groups 1 and 2 (76.9 ± 22.5 vs 93.8 ±
25.3; p < 0.0001) but not between 2 and 3 (112.9 ± 49;
p = 0.076).
Discussion
The relationship of TG levels and glycemic control has
been recognized for a long time, as well as their associa-
tion with cardiovascular mortality when they are above
normal levels (4,5). However, this study suggests that
not only high TG levels are associated with poor glyce-
mic control, but that low TG might also have clinical
implications.
We found hypertriglyceridemia in 10.6% of patients
with T1D, which is similar to the frequency described in
other populations (4). In our study, the group with
higher TG levels had a higher BMI, higher A1C and
used a similar insulin dose than others. This is probably
associated with worse dietary habits in this group.
Moreover, our data indicates that TG < 50 mg/dL are
associated with a more favorable metabolic profile such
as lower HbA1c, BMI, cholesterol and, possibly, insulin
dose. Whether the association between low TG and gly-
cemic control is a cause or a consequence remains to be
elucidated. It is possible that individuals that tend to
have lower TG levels also present genetic (9) or envir-
onmental factors that lead them to a better metabolic
profile. On the other hand, the decrease in TG levels
might only be a consequence of a good glycemic control
or the habit of a low-carbohydrate diet to prevent glyce-
mic excursions (10). None of the individuals had thyroid
diseases that could explain the low TG levels or were
engaged in intense physical activity (11,12). Interestingly,
it has been suggested that individuals with autoimmune
disease have lower TG levels (7) and a significant per-
centage of our sample exhibited TG < 50 mg/dL. It is
possible that the cut-off for high TG levels in these
patients, including those with T1D, should be lower
than the usual parameters. If this is true, the explanation
for our data might be that part of the values that are
considered in the normal range should be actually con-
sidered high for this population with autoimmune dis-
ease. It is possible that by establishing a lower cut-off
Table 1 Clinical parameters according to the TG levels
Low TG Normal TG High TG
Frequency (%) 21.1 68.3 10.6
Age of diagnosis (years) 23.49 (± 6.45) 25.81 (± 9.15) 25.00 (± 7.17)
Duration of disease (years) 11.84 (± 5.47) 12.79 (± 7.3) 13.00 (± 6.7)
BMI (Kg/m
2) 22.58 (± 2.50) 24.33 (± 3.25) 24.37 (± 3.63)
Overweight* (%) 12.2 34.2 42.1
Obesity **(%) 4.9 5.8 15.8
Daily insulin dose
(IU/kg)
0.83 (± 0.30) 1.01 (± 0.47) 0.84 (± 0.31)
Fasting glucose
(mg/dL)
143.37
(± 89.68)
180.11
(± 95.86)
196.24
(± 154.76)
A1 hemoglobin (%) 7.67 (± 1.50) 8.56 (± 1.95) 10.85 (± 1.95)
Total cholesterol
(mg/dL)
144.98
(± 24.68)
166.08
(± 28.35)
216.37
(± 73.43)
LDL (mg/dL) 77.67
(± 22.16)
93.97
(± 25.51)
112.89
(± 49.02)
HDL (mg/dL) 54.0 (± 14.43) 51.14
(± 15.25)
49.31
(± 19.95)
TG (mg/dL) 42.65 (± 5.93) 85.25
(± 26.70)
276.16
(± 11.21)
Table legend: TG = triglycerides; BMI = body mass index; LDL = low density
lipoprotein; HDL = high density lipoprotein; *overweight = BMI≥25 Kg/m
2 ,
**obesity = 30 Kg/m
2 .
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ences would be seen between individuals with low and
normal TG. Studies considering the cardiovascular out-
come are still lacking in lower TG levels, which was not
addressed in this manuscript. One limitation of our
study is the lack of a control group. As the study group
is comprised by young and mostly lean individuals, the
presence of a high frequency of patients with TG < 50
mg/dL might be a characteristic of this age group, inde-
pendently of their disease. Although to our knowledge
the frequency of TG < 50 mg/dL in healthy young indi-
viduals has not been reported, a higher mean of TG
levels was previously identified in young adults when
compared to our data (13). To conclude, TG < 50 mg/
dL are common in patients with T1D in our population
and might be associated with a better metabolic control.
However, it is not clear whether the former is the cause
or the consequence for the latter.
Authors’ contributions
LMA and NES equally participated in the data collection and drafted the
manuscript. JRD performed the statistical analysis and reviewed the
manuscript typography (translation to English language). PBA participated in
the data collection. MMO participated in the data collection and in the
study design. AM participated in the coordination of the study. LZ
participated in the study design and performed the final corrections. MR
conceived the study, performed the statistical analysis and also made the
final corrections. JEPO participated in the study coordination. All contributors
read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 2 February 2011 Accepted: 2 September 2011
Published: 2 September 2011
References
1. Eisenbarth GS: Update in type 1 diabetes. J Clin Endocrinol Metab 2007,
92(7):2403-7.
2. Conway B, Miller RG, Costacou T, Fried L, Kelsey S, Evans RW, et al:
Temporal patterns in overweight and obesity in Type 1 diabetes. Diabet
Med 2010, 27(4):398-404.
3. Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA:
Association between multiple cardiovascular risk factors and
atherosclerosis in children and young adults. The Bogalusa Heart Study.
N Engl J Med 1998, 23(338):650-6.
4. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ,
Raskin P, Zinman B: Diabetes Control and Complications Trial/
Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC)
Study Research Group. Intensive diabetes treatment and cardiovascular
disease in patients with type 1 diabetes. N Engl J Med 2005,
353(25):2643-53.
5. ACCORD Study Group, Gerstein HC, Miller ME, Genuth S, Ismail-Beigi F,
Buse JB, Goff DC Jr, et al: Long-term effects of intensive glucose lowering
on cardiovascular outcomes. N Engl J Med 2008, 358:2545.
6. Chan BL, Lisanti MP, Rodriguez-Boulan E, Saltiel AR: Insulin-stimulated
release of lipoprotein lipase by metabolism of its phosphatidylinositol
anchor. Science 1988, 241(4873):1670-2.
Figure 1 HbA1c according to the groups with low, normal and high triglyceride. TGL: triglyceride level.
Alcantara et al. Diabetology & Metabolic Syndrome 2011, 3:22
http://www.dmsjournal.com/content/3/1/22
Page 3 of 47. Iannello S, Cavaleri A, Milazzo P, Cantarella S, Belfiore F: Low fasting serum
triglyceride level as a precocious marker of autoimmune disorders.
Medscape General Medicine 2003, 5(3), Posted: 08/07/2003; © 2003
Medscape.
8. Oresic M, Simell S, Sysi-Aho M, Näntö-Salonen K, Seppänen-Laakso T,
Parikka V, et al: Dysregulation of lipid and amino acid metabolism
precedes islet autoimmunity in children who later progress to type 1
diabetes. J Exp Med 2008, 205(13):2975-84.
9. Sundaram M, Zhong S, Bou Khalil M, Zhou H, Jiang ZG, Zhao Y, et al:
Functional analysis of the missense APOC3 mutation Ala23Thr
associated with human hypotriglyceridemia. J Lipid Res 2010,
51(6):1524-34.
10. Boling CL, Westman EC, Yancy WS Jr: Carbohydrate-restricted diets for
obesity and related diseases: an update. Curr Atheroscler Rep 2009,
11(6):462-9.
11. Garduño-Garcia Jde J, Alvirde-Garcia U, López-Carrasco G, Padilla
Mendoza ME, Mehta R, Arellano-Campos O, et al: TSH and free thyroxine
concentrations are associated with differing metabolic markers in
euthyroid subjects. Eur J Endocrinol 2010, 163(2):273-8.
12. Magkos F, Wright DC, Patterson BW, Mohammed BS, Mittendorfer B: Lipid
metabolism response to a single, prolonged bout of endurance exercise
in healthy young men. Am J Physiol Endocrinol Metab 2006, 290(2):E355-62.
13. Carrol MD, Lacher DA, Sorlie PD, Cleeman JI, Gordon DJ, Wolz M, et al:
Trends in serum lipids and lipoproteins of adults, 1960-2002. JAMA 2005,
294(14):1773-81.
doi:10.1186/1758-5996-3-22
Cite this article as: Alcantara et al.: Low triglyceride levels are associated
with a better metabolic control in patients with type 1 diabetes.
Diabetology & Metabolic Syndrome 2011 3:22.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Alcantara et al. Diabetology & Metabolic Syndrome 2011, 3:22
http://www.dmsjournal.com/content/3/1/22
Page 4 of 4